Cellectis (CLLS) EBT Margin (2016 - 2023)
Historic EBT Margin for Cellectis (CLLS) over the last 9 years, with Q3 2023 value amounting to 9114.84%.
- Cellectis' EBT Margin rose 42394500.0% to 9114.84% in Q3 2023 from the same period last year, while for Sep 2023 it was 245.16%, marking a year-over-year increase of 2968100.0%. This contributed to the annual value of 314.04% for FY2022, which is 2245100.0% down from last year.
- According to the latest figures from Q3 2023, Cellectis' EBT Margin is 9114.84%, which was up 42394500.0% from 1743.26% recorded in Q2 2023.
- In the past 5 years, Cellectis' EBT Margin registered a high of 1743.26% during Q2 2023, and its lowest value of 13354.29% during Q3 2022.
- In the last 5 years, Cellectis' EBT Margin had a median value of 509.72% in 2021 and averaged 2391.97%.
- Its EBT Margin has fluctuated over the past 5 years, first tumbled by -128445600bps in 2022, then surged by 42394500bps in 2023.
- Quarter analysis of 5 years shows Cellectis' EBT Margin stood at 870.34% in 2019, then soared by 67bps to 286.94% in 2020, then surged by 73bps to 78.67% in 2021, then grew by 5bps to 74.5% in 2022, then tumbled by -12135bps to 9114.84% in 2023.
- Its EBT Margin was 9114.84% in Q3 2023, compared to 1743.26% in Q2 2023 and 12574.82% in Q1 2023.